Published in Health Business Week, April 17th, 2009
There are about 7,000 pharmaceutical companies in China; 4,682 of them produce APIs and intermediates. Among these we chose top 100 pharmas with high growth potential to survey. Our research shows that 40% pharmas have intention to accept overseas contract manufacturing despite the Chinese government's strict policy of international processing trade.
This report provides overseas pharmaceutical companies...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.